Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer

被引：0
|
作者：
Se Hoon Park
Soo-Mee Bang
Eun Kyung Cho
Dong Bok Shin
Jae Hoon Lee
Woon KI Lee
Min Chung
机构：
[1] Gachon Medical School Gil Medical Center,Division of Hematology and Oncology, Department of Internal Medicine
[2] Gachon Medical School Gil Medical Center,Department of General Surgery
来源：
BMC Cancer | / 5卷
关键词：
Gastric Cancer; Docetaxel; Dose Level; Febrile Neutropenia; Dose Escalation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Weekly Docetaxel, Cisplatin, and 5-Fluorouracil as Initial Therapy for Patients With Advanced Gastric and Esophageal Cancer
    Overman, Michael J.
    Kazmi, Syed M.
    Jhamb, Jagriti
    Lin, E.
    Yao, James C.
    Abbruzzese, James L.
    Ho, Linus
    Ajani, Jaffer
    Phan, Alexandria
    CANCER, 2010, 116 (06) : 1446 - 1453
  • [22] Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies
    Bahleda, Rastislav
    Baker, Jackie
    Massard, Christophe
    Gadgeel, Sirish M.
    Rogers, Jane E.
    Izzedine, Hassan
    Deutsch, Eric
    Garris, Jeana L.
    Khan, Akbar
    Boelle, Emmanuelle
    Assadourian, Sylvie
    Soria, Jean-Charles
    Ajani, Jaffer A.
    ONCOLOGY, 2016, 90 (01) : 10 - 20
  • [23] Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
    A Roy
    D Cunningham
    R Hawkins
    H Sörbye
    A Adenis
    J-R Barcelo
    G Lopez-Vivanco
    G Adler
    J-L Canon
    F Lofts
    C Castanon
    E Fonseca
    O Rixe
    J Aparicio
    J Cassinello
    M Nicolson
    M Mousseau
    A Schalhorn
    L D'Hondt
    J Kerger
    D K Hossfeld
    C Garcia Giron
    R Rodriguez
    P Schoffski
    J-L Misset
    British Journal of Cancer, 2012, 107 : 435 - 441
  • [24] Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study
    Roy, A.
    Cunningham, D.
    Hawkins, R.
    Sorbye, H.
    Adenis, A.
    Barcelo, J-R
    Lopez-Vivanco, G.
    Adler, G.
    Canon, J-L
    Lofts, F.
    Castanon, C.
    Fonseca, E.
    Rixe, O.
    Aparicio, J.
    Cassinello, J.
    Nicolson, M.
    Mousseau, M.
    Schalhorn, A.
    D'Hondt, L.
    Kerger, J.
    Hossfeld, D. K.
    Giron, C. Garcia
    Rodriguez, R.
    Schoffski, P.
    Misset, J-L
    BRITISH JOURNAL OF CANCER, 2012, 107 (03) : 435 - 441
  • [25] Docetaxel plus 5-fluorouracil for terminal gastric cancer patients with peritoneal dissemination
    Eguchi, T
    Fujii, M
    Wakabayashi, K
    Aisaki, K
    Tsuneda, Y
    Kochi, M
    Takayama, T
    HEPATO-GASTROENTEROLOGY, 2003, 50 (53) : 1735 - 1738
  • [26] A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer
    Chen, LT
    Liu, TW
    Wu, CW
    Chung, TR
    Shiah, HS
    Jan, CM
    Liu, JM
    Whang-Peng, J
    Chang, JY
    ONCOLOGY, 2002, 63 (03) : 239 - 247
  • [27] Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study
    C Ficorella
    M F Morelli
    E Ricevuto
    K Cannita
    G Porzio
    P Lanfiuti Baldi
    G Cianci
    ZC Di Rocco
    C Natoli
    N Tinari
    F De Galitiis
    F Calista
    P Marchetti
    British Journal of Cancer, 2004, 91 : 618 - 620
  • [28] Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study
    Ficorella, C
    Morelli, MF
    Ricevuto, E
    Cannita, K
    Porzio, G
    Baldi, PL
    Cianci, G
    Di Rocco, ZC
    Natoli, C
    Tinari, N
    De Galitiis, F
    Calista, F
    Marchetti, P
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 618 - 620
  • [29] Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas
    Trarbach, Tanja
    Przyborek, Marta
    Schleucher, Norbert
    Heeger, Steffen
    Luepfert, Christian
    Vanhoefer, Udo
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (03) : 642 - 652
  • [30] Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
    Michael Gubanski
    Anders Johnsson
    Eva Fernebro
    Lianna Kadar
    Ingegerd Karlberg
    Petra Flygare
    Åke Berglund
    Bengt Glimelius
    Pehr A. Lind
    Gastric Cancer, 2010, 13 : 155 - 161
12345